SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001636050-22-000021
Filing Date
2022-02-10
Accepted
2022-02-10 17:07:32
Documents
1
Period of Report
2022-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164453082397281.html 4  
1 FORM 4 wf-form4_164453082397281.xml 4 4109
  Complete submission text file 0001636050-22-000021.txt   5751
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 130 WEST 42ND STREET, 26TH FLOOR NEW YORK NY 10036
Business Address
Meswani Parag V (Reporting) CIK: 0001909324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 22615189